Genotypic detection of rifampicin-resistant M. tuberculosis strains in Syrian and Lebanese patients

Journal of Infection and Public Health

Volumn 5, Issue 6, 2012, Pages 381-387

  Rahmo, Abdulkader ^a   Hamdar, Zahraa ^b   Kasaa, Imad ^b   Dabboussi, Fouad ^b   Hamze, Monzer ^b  

^a National Commission for Biotechnology   (Syrian Arab Republic)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

MDR; Middle East; Molecular diagnostics; Rpo B

Indexed keywords

BACTERIAL DNA; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; GENOTYPE; HUMAN; INCIDENCE; LEBANON; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RIFAMPICIN DRUG RESISTANCE REGION; SYRIAN ARAB REPUBLIC; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; GENOTYPING TECHNIQUES; HUMANS; LEBANON; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; RIFAMPIN; SYRIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84871720193     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2012.07.004     Document Type: Article

References (28)

1. Pablos M.A., Raviglione M.C., Laszlo A., Binkin N., Rieder H.L., Bustreo F., et al. Global surveillance for anti-tuberculosis drug resistance, 1994-1997. New England Journal of Medicine 1998, 338:1641-1649.
2. WHO, 2010/2011. Tuberculosis global facts. Stop tb partnership http://www.who.int/mediacentre/factsheets/fs104/en/.
3. Cohn D.L., Bustreo F., Raviglione M.C. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clinical Infectious Diseases 1997, 24(Suppl. 1):121-130.
4. Kruuner A., Pehme L., Ghebremichael S., Koivula T., Hoffner S.E., Mikelsaar M. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clinical Infectious Diseases 2002, 35:146-155.
5. Douglas J.G., McLeod M.J. Pharmacokinetic factors in the modern drug treatment of tuberculosis. Clinical Pharmacokinetics 1999, 37:127-146.
6. Moore-Gillon J. Multidrug-resistant tuberculosis: this is the cost. Annals of New York Academy of Sciences 2001, 953:233-240.
7. Pontali E., Narain J.P. Tuberculosis and special situations: an annotated bibliography, WHO project: I CP TUB 001. SEA-TB-244. 2002, World Health Organization Regional Office for South-East Asia, New Delhi.
8. Bifani P.J.B., Mathema N.E., Kurepina Kreiswirth B.N. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends in Microbiology 2002, 10:45-52.
9. Mokrousov I.O., Narvskaya T., Otten A., Vyazovaya E., Limeschenko L., Steklova L., et al. Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Research in Microbiology 2002, 153:629-637.
10. Van R.A., Warren R.M., Beyers N., Gie R.P., Classen C.N., Richardson M., et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling " strain W" among noninstitutionalized, human immunodeficiency virus seronegative patients. Journal of Infectious Diseases 1999, 180:1608-1615.
11. Jasmer R.M., Roemer M., Hamilton J., Bunter J., Braden C.R., Shinnick T.M., et al. A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures. Emerging Infectious Diseases 2002, 8:1260-1263.
12. Joel G.H., Limbird L.E., Gillman G.A. Goodman and Gilman's: the harmacological basis of therapeutics 2001, McGraw-Hill. 10th ed.
13. Deepa P., Therese K.L., Madhavan H.N. detection and characterization of mutations in rifampicin resistant mycobacterium tuberculosis clinical isolates by dna sequencing. Indian Journal of Tuberculosis 2005, 52:132-136.
14. Arnold C., Westland L., Mowat G., Underwood A., Magee J., Gharbia S. Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum. Clinical and Microbiological Infection 2005, 11:122-130.
15. Zhao J.R., Bai Y.J., Zhang Q.H., Wang Y., Luo M., Yan X.J. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Diagnostics in Microbiology and Infectious Diseases 2005, 51:135-137.
16. Isola D., Pardini M., Varaine F., Niemann S., Rüsch-Gerdes S., Fattorini L., et al. A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. Journal of Microbiological Methods 2005, 62:113-120.
17. Ronaghi M., Uhlen M., Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998, 281:363-365.
18. Jureen P., Engstrand L., Eriksson S., Alderborn A., Krabbe M., Hoffner S. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by pyrosequencing technology. Journal of Clinical Microbiology 2006, 44:1925-1929.
19. WHO. Tuberculosis country profiles http://www.who.int/tb/country/data/profiles/en/index.html.
20. Hamze M., Rahmo A., Saade M. Characterization of Mycobacterium tuberculosis of Lebanese patients by double-repetitive-element polymerase chain reaction. Eastern Mediterranean Health Journal 2010, 16(8):812-819.
21. Rahmo A., Hamze M. Characterization of Mycobacterium Tuberculosis in Syrian patients by double-repetitive-element polymerase chain reaction. Eastern Mediterranean Health Journal 2010, 16(8):820-830.
22. Tricia L., Bravo C., Marion J. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. Journal of Clinical Microbiology 2009, 47:3985-3990.
23. TB drug resistance mutation data base. [accessed at 08.08.11]. http://www.tbdreamdb.com/Other.html.
24. Zhang Y. The magic bullets and tuberculosis drug targets. Annual Review of Pharmacology and Toxicology 2005, 45:529-564.
25. Cavusoglu C., Hilmioglu S., Guneri S., Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. Journal of Clinical Microbiology 2002, 40:4435-4438.
26. Mani C., Selvakumar N., Narayanan S., Narayanan P.R. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. Journal of Clinical Microbiology 2001, 39:2987-2990.
27. Sekiguchi J., Miyoshi-Akiyama T., Augustynowicz-Kope E., Zwolska Z., Kirikae F., Toyota E., et al. Detection of multidrug resistance in Mycobacterium tuberculosis. Journal of Clinical Microbiology 2007, 1:179-192.
28. Ahmad S., Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respiratory Medicine CME 2010, 3:51-61.